KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Gains from Sales and Divestitures (2021 - 2025)

LifeMD (LFMD) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $200000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 20.0% year-over-year to $200000.0, compared with a TTM value of $200000.0 through Dec 2025, down 20.0%, and an annual FY2025 reading of $200000.0, down 20.0% over the prior year.
  • Gains from Sales and Divestitures was $200000.0 for Q4 2025 at LifeMD, roughly flat from $200000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.5 million in Q2 2025 and bottomed at $26875.0 in Q2 2021.
  • Average Gains from Sales and Divestitures over 5 years is $343913.7, with a median of $177125.0 recorded in 2022.
  • Peak annual rise in Gains from Sales and Divestitures hit 1841.07% in 2025, while the deepest fall reached 84.44% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $77875.0 in 2021, then skyrocketed by 127.45% to $177125.0 in 2022, then skyrocketed by 120.18% to $390000.0 in 2023, then tumbled by 35.9% to $250000.0 in 2024, then decreased by 20.0% to $200000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for LFMD at $200000.0 in Q4 2025, $200000.0 in Q3 2025, and $1.5 million in Q2 2025.